The capital cost of technology has been sharply increasing in recent years with Varian and Elekta and others developing some great products. However, a large part of the Lifetime Cost of this technology is maintenance and service; a monopoly has developed because the original equipment manufacturer (OEM) controls more of the service than normal for complex medical technology, and annual costs are rising disproportionately.
Failure to attack technology lifetime costs inevitably results in a focus on reductions in the patient facing staff you’ve invested in who ensure excellent patient experience and outcomes. As a result, it makes sense to revisit ways to spend less to maintain clinical up-time.
It is generally agreed that negotiating with a monopoly rarely leads to the optimum outcome for the buyer, which is why Acceletronics, as an Independent Linear Accelerator Services Organization, is so important to the future of your Cancer Clinic. Continue reading “Independent Linear Accelerator Services Vital to Future of Healthcare”